GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $878,000 | +73.2% | 5,210 | 0.0% | 0.04% | +66.7% |
| Q4 2018 | $507,000 | -43.7% | 5,210 | 0.0% | 0.02% | -38.5% |
| Q3 2018 | $900,000 | +23.8% | 5,210 | 0.0% | 0.04% | +14.7% |
| Q2 2018 | $727,000 | +23.9% | 5,210 | 0.0% | 0.03% | +41.7% |
| Q1 2018 | $587,000 | -14.7% | 5,210 | 0.0% | 0.02% | -25.0% |
| Q4 2017 | $688,000 | +27.9% | 5,210 | -1.7% | 0.03% | +14.3% |
| Q3 2017 | $538,000 | -54.6% | 5,300 | -45.9% | 0.03% | -58.2% |
| Q1 2017 | $1,185,000 | – | 9,800 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|